Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
Phase 2
70
about 3.4 years
18+
Male only
1 site in OH
What this study is about
This trial is testing whether relugolix or leuprolide affects the heart and physical performance in men with prostate cancer. The goal is to see if relugolix might be better for heart health compared to leuprolide, a common treatment for prostate cancer.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Contrast Agent
- 2.Physical Performance Testing
- 3.Take Leuprolide
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
leuprorelin (GnRH agonist; suppresses testosterone (and estrogen) production after initial surge), relugolix
oral (Oral Tablet)
Secondary: Quality of life using EORTC QLQ-C30, Quality of life using EPIC-26, Quality of life using European (Euro) Qol-5-Dimension 5-level (EQ-5D-5L), Quality of life using PROMIS
diagnostic, imaging
Oncology